Publicaciones en colaboración con investigadores/as de University of Amsterdam (41)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

  2. Workflow to facilitate the detection of new psychoactive substances and drugs of abuse in influent urban wastewater

    Journal of Hazardous Materials, Vol. 469

2023

  1. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 5, pp. 1169-1203

2022

  1. TRIB3 Modulates PPARγ-Mediated Growth Inhibition by Interfering with the MLL Complex in Breast Cancer Cells

    International journal of molecular sciences, Vol. 23, Núm. 18

2021

  1. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 3, pp. 648-676

  2. Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 8, pp. 2337-2353

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Corrigendum to “Enantiomeric profiling of quinolones and quinolones resistance gene qnrS in European wastewaters” [Water Res. 175 (2020) 115653] (Water Research (2020) 175, (S0043135420301895), (10.1016/j.watres.2020.115653))

    Water Research

  2. Enantiomeric profiling of quinolones and quinolones resistance gene qnrS in European wastewaters

    Water Research, Vol. 175

  3. Spatio-temporal assessment of illicit drug use at large scale: evidence from 7 years of international wastewater monitoring

    Addiction, Vol. 115, Núm. 1, pp. 109-120

2019

  1. Contribution of altered endocannabinoid system to overactive mTORC1 signaling in focal cortical dysplasia

    Frontiers in Pharmacology, Vol. 9, Núm. JAN

  2. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 74, Núm. 5, pp. 855-873

2018

  1. Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 4, pp. 816-826

  2. Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 1, pp. 64-76

  3. Comparison of phosphodiesterase type V inhibitors use in eight European cities through analysis of urban wastewater

    Environment International, Vol. 115, pp. 279-284

  4. Enantiomeric profiling of chiral illicit drugs in a pan-European study

    Water Research, Vol. 130, pp. 151-160

2017

  1. Estimation of caffeine intake from analysis of caffeine metabolites in wastewater

    Science of the Total Environment, Vol. 609, pp. 1582-1588

  2. Liquid chromatography-tandem mass spectrometry determination of synthetic cathinones and phenethylamines in influent wastewater of eight European cities

    Chemosphere, Vol. 168, pp. 1032-1041

  3. Wastewater-based epidemiology to assess pan-European pesticide exposure

    Water Research, Vol. 121, pp. 270-279

2016

  1. Increased levels of the oxidative stress biomarker 8-iso-prostaglandin F 2α in wastewater associated with tobacco use

    Scientific Reports, Vol. 6